Hu Lane anticipates recovery in 2H25 amid profit challenges from currency swings
Automotive connector manufacturer Hu Lane faced significant profitability challenges in the second quarter of 2025 due to the traditional industry…
SBC Medical se une a la membresía del índice Russell 3000®
IRVINE, California–(BUSINESS WIRE)–SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), franquicia global y proveedor de servicios para clínicas estéticas,…
SBC Medical devient membre de l'indice Russell 3000®
IRVINE, Californie–(BUSINESS WIRE)–SBC Medical Group Holdings Incorporated (Nasdaq : SBC) (« SBC Medical »), une franchise mondiale et un fournisseur…
SBC Medical被納入羅素3000®指數成分股
加州爾灣–(BUSINESS WIRE)–(美國商業資訊)– 全球美妝診所特許經營商及服務提供者SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”)已被納入涵蓋廣泛市場的羅素3000®指數成分股，於6月30日美國市場開盤後生效，此為2025年羅素指數重新調整的一部分。 羅素3000®指數的成分股資格將維持一年，這表示該公司將自動納入大型股羅素1000® 指數或小型股羅素2000® 指數，以及相應的成長型和價值型風格指數。 羅素指數被投資管理公司和機構投資人廣泛用於指數基金，並做為主動投資策略的基準。截至2024年6月底的資料顯示，約10.6兆美元的資產以屬於全球指數供應商FTSE Russell的羅素美國指數為基準。 LSEG旗下FTSE Russell的執行長Fiona Bassett評論道： 「羅素指數持續適應不斷發展的美國經濟動態，全面重新校準羅素美國指數系列至關重要，以確保這些指數保持對市場的準確表徵。從2026年起轉換到半年一次的重新調整頻率，將確保我們的指數繼續代表市場，並維持指數做
Help Patients Prevent and Treat Dry Mouth
OTC saliva substitutes and avoiding alcohol can help alleviate dry mouth symptoms.
PCAB Accreditation as a Safety Net: GLP-1 Demand and the Spotlight on Compounding Standards
As compounded medications gain popularity amid drug shortages, concerns about safety, quality, and regulation have intensified, making Pharmacy Compounding Accreditation…
Is Belantamab Mafodotin Making a Comeback?
The agent continues to show promising clinical benefit despite being pulled from the market in 2023.
Thimerosal Reenters Public Debate as ACIP Scrutinizes Use in Influenza Vaccines
With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out…